Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Hoffmann, Peter [VerfasserIn]   i
 Krisam, Johannes [VerfasserIn]   i
 Kasperk, Christian [VerfasserIn]   i
 Gauss, Annika [VerfasserIn]   i
Titel:Prevalence, risk factors and course of osteoporosis in patients with Crohn’s disease at a tertiary referral center
Verf.angabe:Peter Hoffmann, Johannes Krisam, Christian Kasperk and Annika Gauss
E-Jahr:2019
Jahr:10 December 2019
Umfang:12 S.
Fussnoten:Gesehen am 12.02.2020
Titel Quelle:Enthalten in: Journal of Clinical Medicine
Ort Quelle:Basel : MDPI, 2012
Jahr Quelle:2019
Band/Heft Quelle:8(2019,12) Artikel-Nummer 2178, 12 Seiten
ISSN Quelle:2077-0383
Abstract:Background: Patients with Crohn's disease are at increased risk for fractures due to low bone mineral density (BMD). Real-world data are necessary to optimize surveillance and treatment strategies. Methods: Patients with Crohn's disease who underwent at least one dual-energy X-ray absorptiometry (DXA) scans were recruited. The primary study endpoints were (1) prevalence of osteoporosis, and (2) factors influencing changes of BMD. To identify potential risk factors for reduced BMD, Mann-Whitney U-test was used for ordinal and continuous variables and x2-tests for categorical variables. Results with p < 0.05 were included in a multivariable analysis. To identify potential factors influencing changes in BMD, a generalized linear mixed model was applied. Results: 39.9% of the patients were diagnosed with normal BMD, 40.2% with osteopenia, and 19.8% with osteoporosis. The main risk factors for osteoporosis were low body mass index (BMI), previous bowel resections and male sex. The main risk factors for reduced BMD during further along the disease course were steroid use, history of immunomodulator treatment, female sex and decreased BMI. Conclusion: Low BMI, previous bowel resections and male sex were the main risk factors for the development of osteoporosis. Steroid use reduced BMD even under anti-inflammatory therapy, underlining that they should be used with great care in that patient group.
DOI:doi:10.3390/jcm8122178
URL:kostenfrei: Volltext: https://doi.org/10.3390/jcm8122178
 kostenfrei: Verlag: https://www.mdpi.com/2077-0383/8/12/2178
 DOI: https://doi.org/10.3390/jcm8122178
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:bisphosphonates
 bone mineral density
 Crohn’s disease
 inflammatory bowel disease
 osteopenia
 osteoporosis
 steroids
K10plus-PPN:1689880902
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68488007   QR-Code
zum Seitenanfang